MariMed CEO converts stock award into 11,517 shares

The chief executive officer's remaining RSUs under the grant will vest in full on April 2, 2027.

Rhea-AI Filing Summary

On October 2, 2026, Marimed Inc. President and CEO Jon R. Levine converted 11,517 restricted stock units into 11,517 common shares on a one-for-one basis. The issuer withheld 3,991 shares to satisfy tax-withholding obligations tied to vesting; no Rule 10b5-1 plan is reported. Christine A. Levine, Jon R. Levine’s spouse, holds 6,684,640 shares, and Jon R. Levine disclaims beneficial ownership of them.

Insider Trade Summary

11,517 shares exercised/converted

Exercise 4 txns

Insider Levine Jon R

Role President and CEO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU) F1, F4	11,517	$0.00	$0.00
Exercise	Common stock F1	11,517	$0.00	$0.00
Tax Withholding	Common stock F2	3,991	$0.0696	$277.77
holding	Common stock F3	--	--	--

Holdings After Transaction: Restricted Stock Units (RSU) — 11,517 contracts (Direct); Common stock — 21,366,157 shares (Direct); Common stock — 6,684,640 shares (Indirect, By Christine A. Levine)

Footnotes (4)

1. F1. RSUs convert to shares of common stock on a one-for-one basis.
2. F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. F3. These shares are held by Christine A. Levine, the Reporting Peron's spouse. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4. F4. The RSUs were granted on April 2, 2024; the remaining RSUs under this grant will vest in full on April 2, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs converted: 11,517 RSUs Common shares acquired: 11,517 shares Shares withheld for tax obligations: 3,991 shares +1 more

4 metrics

RSUs converted 11,517 RSUs October 2, 2026

Common shares acquired 11,517 shares October 2, 2026

Shares withheld for tax obligations 3,991 shares In connection with RSU vesting on October 2, 2026

Shares held by Christine A. Levine 6,684,640 shares Indirect holding; Jon R. Levine disclaims beneficial ownership

Key Terms

Restricted Stock Units (RSU), tax withholding obligations, beneficial ownership, award agreement

4 terms

Restricted Stock Units (RSU) financial

"Restricted Stock Units (RSU)"

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with the vesting of RSUs"

beneficial ownership regulatory

"disclaims beneficial ownership of these securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

award agreement financial

"in accordance with the terms of an award agreement"

An award agreement is a legal contract that spells out the terms of a pay or equity grant—such as stock options, restricted shares, or cash bonuses—given to an employee, director or consultant. It describes what is being granted, any conditions for keeping it (for example, earning it over time or meeting performance targets), and what happens if the person leaves or breaks rules. Investors care because these agreements affect company costs, potential share dilution and how executives are motivated and rewarded.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MRMD CEO Jon R. Levine report?

On October 2, 2026, Marimed Inc. President and CEO Jon R. Levine converted 11,517 RSUs into 11,517 common shares on a one-for-one basis. The issuer withheld 3,991 shares for tax obligations tied to vesting, and no Rule 10b5-1 plan is reported.

When will the remaining MRMD RSUs under the grant vest?

The remaining RSUs under the grant will vest in full on April 2, 2027, in accordance with the award agreement between Marimed Inc. and Jon R. Levine.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 04:06 PM Accepted by SEC EDGAR 10/02/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levine Jon R

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD, MASSACHUSETTS 02062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	10/02/2026		M		11,517	A	$0(1)	21,370,148	D
Common stock	10/02/2026		F		3,991(2)	D	$0.0696	21,366,157	D
Common stock								6,684,640	I	By Christine A. Levine(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	10/02/2026		M			11,517	(4)	(4)	Common Stock, par value $.001 per share	11,517	$0	11,517	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. These shares are held by Christine A. Levine, the Reporting Peron's spouse. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

4. The RSUs were granted on April 2, 2024; the remaining RSUs under this grant will vest in full on April 2, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Jon R. Levine	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)